Matthew K Fust Atara Biotherapeutics, Inc. (ATRA) insider trading activity

ATRA Quotes by TradingView

Matthew K Fust is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 259,000 shares of ATRA, which is worth approximately $2.77 Million. The most recent transaction as insider was on Mar 31, 2024, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 259K
0% 3M change
137.61% 12M change
Total Value Held $2.77 Million

Matthew K Fust Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2024
BUY
Grant, award, or other acquisition
-
150,000 Added 36.67%
259,000 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
57,000 Added 34.34%
109,000 Common Stock
Jun 23 2022
BUY
Grant, award, or other acquisition
-
20,500 Added 28.28%
52,000 Common Stock
Nov 04 2021
SELL
Open market or private sale
$260,403 $19.5 p/Share
13,354 Reduced 29.77%
31,500 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 19.69%
44,854 Common Stock

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
RARE
Ultragenyx Pharmaceutical Inc. Healthcare
NMRA
Neumora Therapeutics, Inc.
MKF

Matthew K Fust

San Diego, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRA